Clinical trial / 2014
Leucocytotoxic test-based exclusion diets improved reflux symptoms in non-responders to proton pump inhibitors.
In this double-blind pilot trial, 38 patients with reflux who had inadequate responses to medication received either a true exclusion diet (n = 20) or a control diet (n = 18) for one month. At one month, symptom severity scores dropped more in the true diet group (-50%, P = 0.001) than in controls (-26.9%, P = 0.02), yielding significantly lower scores (P = 0.04). When the control group switched to the true exclusion diet, their symptom scores decreased further (-44.9%, P = 0.01).
- Study type
- Randomized controlled pilot trial
- Who was studied
- 38 adults with gastro-esophageal reflux disease
- What was measured
- GERD symptom severity
THE PAPER
Test-based exclusion diets in gastro-esophageal reflux disease patients: a randomized controlled pilot trial.
Caselli M, Zuliani G, Cassol F, Fusetti N, Zeni E, Lo Cascio N, Soavi C, Gullini S. World J Gastroenterol, 2014.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.